Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination
November 12, 2019
November 12, 2019
NEW YORK, Nov. 12 -- Pfizer, a pharmaceutical company, issued the following news release:
HERTFORDSHIRE, England & PITTSBURGH & Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be Viatris (pronounced 'viE-tris).
Deriving its name from Latin, Viatris embodies the new company's goal of providing a path--"VIA"--to th . . .
HERTFORDSHIRE, England & PITTSBURGH & Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be Viatris (pronounced 'viE-tris).
Deriving its name from Latin, Viatris embodies the new company's goal of providing a path--"VIA"--to th . . .